0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Karyopharm Therapeutics Inc - Trending symbols

Latest News of Karyopharm Therapeutics Inc

DateTitleRead
2025-10-09
22:36
UWM Holdings (UWMC) Shares Cross Below 200 DMARead



Trends

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Net Working Capital 150,921-27,659123,262-59,03464,228-34,36029,868-31,214-1,346
Net Invested Capital 2,17256,81958,991-28,04630,945-29,5881,357-27,950-26,593
Interest Expense 5,8843,0658,9492,43611,385-18111,204-22,198-10,994
Tax Provision 130-5971-467-3928-137-109
Income Tax Expense 130-5971-467-3928-137-109
Income before Tax -32,503-1,991-34,494-7,213-41,7074,416-37,29161,15023,859
Net Income -32,630-1,876-34,506-7,331-41,8374,475-37,36261,15423,792
Net Income from Continuing Operations -32,630-1,876-34,506-7,331-41,8374,475-37,36261,15423,792
Total Other Income Expense Net -6,033593-5,440876-4,5641,391-3,1733,20330
Depreciation and Amortization 13938177-2814933182-703-521
Common Stock 7180808-79,681-79,673
EBIT -36,287-15,883-52,1703,723-48,4474,751-43,69690,23546,539
EBITDA -36,030-15,905-51,9353,717-48,2184,708-43,51090,18846,678
Net non Operating Income Other 779-576203398601-485116-539-423
Operating Income -37,066-15,307-52,3733,325-49,0485,236-43,81290,77446,962
Net Income Applicable to Common Shares -43,421-13,993-57,4143,832-53,5821,770-51,81290,53238,720

Comments

How you think about this?

Leave a comment

Stay informed about Karyopharm Therapeutics Inc.

Receive notifications about Karyopharm Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.